LHC Group, Inc.  

(Public, NASDAQ:LHCG)   Watch this stock  
Find more results for LHCG
29.72
-0.72 (-2.37%)
Jan 30 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 29.35 - 30.92
52 week 19.69 - 32.01
Open 30.22
Vol / Avg. 103,148.00/72,204.00
Mkt cap 528.97M
P/E 24.14
Div/yield     -
EPS 1.23
Shares 17.80M
Beta 1.19
Inst. own 77%
Mar 3, 2015
Q4 2014 LHC Group Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Jan 15, 2015
LHC Group Inc at JPMorgan Healthcare Conference
Dec 11, 2014
LHC Group Inc at Oppenheimer Healthcare Conference
Nov 6, 2014
Q3 2014 LHC Group Inc Earnings Call
Nov 5, 2014
Q3 2014 LHC Group Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 4.18% 4.43%
Operating margin 6.49% 7.10%
EBITD margin - 8.37%
Return on average assets 6.34% 7.20%
Return on average equity 8.03% 7.96%
Employees 5,268 -
CDP Score - -

Address

420 WEST PINHOOK ROAD
LAFAYETTE, LA 70503
United States - Map
+1-337-2331307 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

LHC Group, Inc. (LHC Group) is engaged in provide post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals (LTACHs). As of December 31, 2013, through the Company�s wholly and majority owned subsidiaries, equity joint ventures and controlled affiliates, the Company operated in Alabama, Arkansas, California, Florida, Georgia, Idaho, Illinois, Kentucky, Louisiana, Maryland, Minnesota, Mississippi, Missouri, Nevada, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, West Virginia and Wisconsin. The Company operates in two segments: home-based services and facility-based services. The Company�s home-based services offered through its home nursing agencies and hospices. The Company�s LTACHs treat patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel.

Officers and directors

Keith G. Myers Chairman of the Board, Chief Executive Officer
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Donald D. Stelly President, Chief Operating Officer
Age: 45
Bio & Compensation  - Reuters
Jeffrey M. Kreger Senior Vice President - Finance
Age: 46
Bio & Compensation  - Reuters
Joshua L. Proffitt Executive Vice President, General Counsel, Secretary
Age: 36
Bio & Compensation  - Reuters
Rexanne Domico Senior Vice President - Home Care and Hospice Operations
Bio & Compensation  - Reuters
W.J. Tauzin Lead Independent Director
Age: 70
Bio & Compensation  - Reuters
John L. Indest Director
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Brent Turner MBA Director
Bio & Compensation  - Reuters
Monica F. Azare Independent Director
Age: 47
Bio & Compensation  - Reuters
John B. Breaux Independent Director
Age: 70
Bio & Compensation  - Reuters